Skip to content

Outset Medical, Inc. OM Return on equity

Return on equity at other companies

Baxter International logo
Baxter InternationalBAX
-16.7%-76.7pp
DaVita logo
DaVitaDVA
159.1%+80.9pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp
Haemonetics logo
HaemoneticsHAE
19.3%+5.2pp
CorMedix logo
CorMedixCRMD
65.6%
Teladoc Health logo
Teladoc HealthTDOC
-12.4%-5.4pp

Other financials

Income statement

See full
Revenue$27.9M-6.3%
Gross profit$12.1M+9.3%
Operating income-$16.9M-3.2%
Net income-$19.0M+26.4%
EPS (diluted)-$1.03+71.9%

Balance sheet

See full
Cash & equivalents$30.6M-59.7%
Total debt$101.6M+3.5%
Total equity$111.7M-34.3%
Total assets$249.5M-17.2%

Cash flow

See full
Operating cash flow-$12.8M+50.0%
CapEx$65.0K-47.2%
Free cash flow-$12.9M+49.9%

Valuation

See full
Market cap$80.08M-77.6%
Enterprise value$151.13M-63.6%
P/S0.7×-2.3×

Profitability

See full
Gross margin40.6%+4.7pp
Operating margin-57.2%-12.9pp
Net margin-63.7%-16.7pp
FCF margin-29.1%-11.5pp

Returns & leverage

See full
Debt / equity0.9×+0.3×
Current ratio6.3×-2.1×

Where this comes from

Calculated from Outset Medical, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Outset Medical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Outset Medical, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Outset Medical, Inc.'s return on equity?
Outset Medical, Inc. (OM) reported return on equity of -53.2% in Q1 2026.
How has Outset Medical, Inc.'s return on equity changed year-over-year?
Outset Medical, Inc.'s return on equity increased by 38.6% year-over-year, from -86.5% to -53.2%.
What is the long-term trend for Outset Medical, Inc.'s return on equity?
Over 4 years (2021 to 2025), Outset Medical, Inc.'s return on equity has grown at a 29.7% compound annual growth rate (CAGR), from -37.6% to -106.2%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.